Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: EE Times today

<Even if TPL loses the ownership (title) issue TPL may still control just about all CM's ownership rights.>

Yes, until Moore undos the master agreement which he and Patriot could do. The terms of the MA require 75% owership agreement to terminate. I construe ownership as meaning title. If TPL loses ownership, in all liklihood TPL looses it all. IMHO.

You have made your speculation and defended it. I have made some counter-arguments which I believe help to clarify what the probablility is of your speculation ever coming about in the near term.

Personally, I don't think it's worth kicking this can down the road any further. Hope you agree.

Opty

Share
New Message
Please login to post a reply